GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (OSTO:GETI B) » Definitions » Cyclically Adjusted Price-to-FCF

Getinge AB (OSTO:GETI B) Cyclically Adjusted Price-to-FCF : 14.61 (As of Jul. 01, 2025)


View and export this data going back to 1998. Start your Free Trial

What is Getinge AB Cyclically Adjusted Price-to-FCF?

As of today (2025-07-01), Getinge AB's current share price is kr189.70. Getinge AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was kr12.98. Getinge AB's Cyclically Adjusted Price-to-FCF for today is 14.61.

The historical rank and industry rank for Getinge AB's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

OSTO:GETI B' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 9.94   Med: 16.25   Max: 35.56
Current: 14.5

During the past years, Getinge AB's highest Cyclically Adjusted Price-to-FCF was 35.56. The lowest was 9.94. And the median was 16.25.

OSTO:GETI B's Cyclically Adjusted Price-to-FCF is ranked better than
80.65% of 248 companies
in the Medical Devices & Instruments industry
Industry Median: 35.645 vs OSTO:GETI B: 14.50

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Getinge AB's adjusted free cash flow per share data for the three months ended in Mar. 2025 was kr0.576. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is kr12.98 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Getinge AB Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Getinge AB's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getinge AB Cyclically Adjusted Price-to-FCF Chart

Getinge AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.03 32.42 16.54 16.90 13.86

Getinge AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.85 13.29 16.09 13.86 16.63

Competitive Comparison of Getinge AB's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Getinge AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Getinge AB's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Getinge AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Getinge AB's Cyclically Adjusted Price-to-FCF falls into.


;
;

Getinge AB Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Getinge AB's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=189.70/12.98
=14.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Getinge AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Getinge AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.576/132.8245*132.8245
=0.576

Current CPI (Mar. 2025) = 132.8245.

Getinge AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.855 99.995 1.136
201509 1.707 100.228 2.262
201512 2.987 100.276 3.957
201603 2.760 100.751 3.639
201606 1.837 101.019 2.415
201609 2.999 101.138 3.939
201612 7.375 102.022 9.602
201703 2.002 102.022 2.606
201706 -0.720 102.752 -0.931
201709 0.737 103.279 0.948
201712 2.232 103.793 2.856
201803 -0.007 103.962 -0.009
201806 0.088 104.875 0.111
201809 2.919 105.679 3.669
201812 1.123 105.912 1.408
201903 0.492 105.886 0.617
201906 2.115 106.742 2.632
201909 2.126 107.214 2.634
201912 4.857 107.766 5.986
202003 3.609 106.563 4.498
202006 4.971 107.498 6.142
202009 5.720 107.635 7.059
202012 8.294 108.296 10.173
202103 6.792 108.360 8.325
202106 4.501 108.928 5.488
202109 4.589 110.338 5.524
202112 4.788 112.486 5.654
202203 1.498 114.825 1.733
202206 0.455 118.384 0.511
202209 3.671 122.296 3.987
202212 2.570 126.365 2.701
202303 -2.636 127.042 -2.756
202306 0.988 129.407 1.014
202309 3.921 130.224 3.999
202312 3.613 131.912 3.638
202403 3.455 132.205 3.471
202406 1.050 132.716 1.051
202409 1.303 132.304 1.308
202412 6.190 132.987 6.182
202503 0.576 132.825 0.576

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Getinge AB  (OSTO:GETI B) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Getinge AB Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Getinge AB's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Getinge AB Business Description

Traded in Other Exchanges
Address
Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, SE-417 56
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.

Getinge AB Headlines

No Headlines